Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study

Dissertation (MSc (Pharmacology))--University of Pretoria, 2020.

Saved in:
Bibliographic Details
Other Authors: Marais, Andrè
Format: Thesis
Language:English
Published: University of Pretoria 2020
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613436963192832
access_status_str Open Access
author2 Marais, Andrè
author_browse Marais, Andrè
author_facet Marais, Andrè
collection Thesis
dc_rights_str_mv © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Dissertation (MSc (Pharmacology))--University of Pretoria, 2020.
format Thesis
id oai:repository.up.ac.za:2263/76007
institution University of Pretoria (South Africa)
language English
last_indexed 2026-06-10T12:36:07.570Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2020
publishDateRange 2020
publishDateSort 2020
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/76007 Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study Marais, Andrè elandre.kok@gmail.com Steenkamp, Vanessa Kok, Elandre Anaemia Chronic kidney disease (CKD) Erythropoiesis stimulating agent Haemoglobin Iron UCTD Health sciences theses SDG-03 Dissertation (MSc (Pharmacology))--University of Pretoria, 2020. Anaemia in chronic kidney disease (CKD) mostly results from a decrease in the production of erythropoietin (EPO) by the failing kidney. CKD progression requires treatment with erythropoiesis-stimulating agents and iron supplementation to ensure sufficient erythrocyte production. Best clinical practice guidelines should be adhered to in managing CKD to reduce morbidity and mortality related to anaemia associated cardiovascular disease. Likewise, guideline deviations create an increased strain on the resources of the treatment facility. It is uncertain to which extent these guidelines are followed by Nephrology Units in the public healthcare sector, or whether the documented international trends are prevalent locally due to the paucity of local data, and therefore further investigation is warranted. This study aimed to assess treatment trends in managing anaemia in CKD patients at the Steve Biko Academic Hospital (SBAH). Files of patients receiving treatment at the SBAH Nephrology Unit between 2 January 2018 - 31 August 2018 were reviewed. Only individuals with stage 5 CKD receiving either haemodialysis, or peritoneal dialysis were included, while those with less than three months’ treatment were excluded. Measured variables included demographical information, current EPO treatment and/or iron supplementation regimens versus serum haemoglobin/iron levels and quantity of administered blood products. Ninety-seven patients met the inclusion criteria. Haemodialysis accounted for 43% (n = 42), and peritoneal dialysis 57% (n = 55). Intergroup comparison between the number of results where both haemoglobin and iron were within the target range versus the number of results where both parameters fell outside the target range yielded a significant difference (p = 0.0031). Patients receiving peritoneal dialysis reached serum haemoglobin and iron levels closer to normal target values compared to those receiving haemodialysis. Managing anaemia in CKD is a complex process. More stringent iron control, especially for patients receiving haemodialysis, including the administration of long-acting EPO preparations once a month, is proposed. The latter will contribute to the improvement of clinical outcomes of patients with CKD. em2026 Pharmacology MSc (Pharmacology) Unrestricted SDG-03: Good health and well-being 2020-09-01T06:26:52Z 2020-09-01T06:26:52Z 2020-10-02 2020 Dissertation Kok, E 2020, Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study, MSc Dissertation, University of Pretoria, Pretoria, viewed yymmdd http://hdl.handle.net/2263/76007 S2020 http://hdl.handle.net/2263/76007 en © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle Anaemia
Chronic kidney disease (CKD)
Erythropoiesis stimulating agent
Haemoglobin
Iron
UCTD
Health sciences theses SDG-03
Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study
title Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study
title_full Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study
title_fullStr Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study
title_full_unstemmed Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study
title_short Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study
title_sort erythropoietin treatment in anaemic patients at the nephrology unit of the steve biko academic hospital a retrospective cross sectional study
topic Anaemia
Chronic kidney disease (CKD)
Erythropoiesis stimulating agent
Haemoglobin
Iron
UCTD
Health sciences theses SDG-03
url http://hdl.handle.net/2263/76007